Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Total Debt (2016 - 2024)

Cross Country Healthcare's Total Debt history spans 15 years, with the latest figure at $4.4 million for Q4 2024.

  • For Q4 2024, Total Debt fell 35.08% year-over-year to $4.4 million; the TTM value through Dec 2024 reached $4.4 million, down 35.08%, while the annual FY2024 figure was $4.4 million, 35.08% down from the prior year.
  • Total Debt reached $4.4 million in Q4 2024 per CCRN's latest filing, up from $4.1 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $226.7 million in Q1 2022 to a low of $4.1 million in Q1 2024.
  • Average Total Debt over 5 years is $84.2 million, with a median of $61.8 million recorded in 2020.
  • Peak YoY movement for Total Debt: skyrocketed 244.27% in 2021, then tumbled 97.28% in 2024.
  • A 5-year view of Total Debt shows it stood at $53.4 million in 2020, then surged by 244.27% to $183.9 million in 2021, then fell by 15.03% to $156.2 million in 2022, then crashed by 95.65% to $6.8 million in 2023, then tumbled by 35.08% to $4.4 million in 2024.
  • Per Business Quant, the three most recent readings for CCRN's Total Debt are $4.4 million (Q4 2024), $4.1 million (Q3 2024), and $4.1 million (Q2 2024).